Literature DB >> 10946324

Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells.

H R Salih1, S G Kosowski, V F Haluska, G C Starling, D T Loo, F Lee, A A Aruffo, P A Trail, P A Kiener.   

Abstract

Members of the TNF superfamily, including Fas, Fas ligand, and CD40, have been shown to be expressed on tumor cells. In the studies described in this work, we report that another family member, the ligand for 4-1BB (CD137), is expressed on various human carcinoma cell lines, on cells of solid tumors derived from these cell lines, and cells obtained from human tumors. Expression of 4-1BB ligand (4-1BBL) mRNA was detected by both RT-PCR and Northern blot analysis, and expression of 4-1BBL protein was detected by Western blot analysis of whole cell lysates and by FACS analysis of tumor cells and cell lines. Incubation of tumor cells with a 4-1BB-Ig fusion protein led to the production of IL-8 by the cells, demonstrating that the 4-1BBL is functionally active and signals back into the tumor cells. Furthermore, 4-1BBL expressed on the carcinoma cells functioned as a costimulatory molecule for the production of cytokines (most notably IFN-gamma) in cocultures of T cells and tumor cells. These findings suggest that 4-1BBL expressed on carcinoma cells may significantly influence the outcome of a T cell-tumor cell interaction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10946324     DOI: 10.4049/jimmunol.165.5.2903

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  High-density oligonucleotide microarrays and functional network analysis reveal extended lung carcinogenesis pathway maps and multiple interacting genes in NNK [4-(methylnitrosamino)-1-(3-pyridyle)-1-butanone] induced CD1 mouse lung tumor.

Authors:  Hekmat Osman Abdel-Aziz; Ichiro Takasaki; Yoshiaki Tabuchi; Kazuhiro Nomoto; Yoshihiro Murai; Koichi Tsuneyama; Yasuo Takano
Journal:  J Cancer Res Clin Oncol       Date:  2006-09-15       Impact factor: 4.553

2.  TNFSF9 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Pancreatic Cancer.

Authors:  Jiao Wu; Yunpeng Wang; Zheng Jiang
Journal:  J Gastrointest Cancer       Date:  2021-03

3.  CD137 ligand-mediated reverse signaling inhibits proliferation and induces apoptosis in non-small cell lung cancer.

Authors:  Yingying Qian; Dong Pei; Ting Cheng; Changling Wu; Xiaolin Pu; Xiaofeng Chen; Yiqian Liu; Hong Shen; Weiwei Zhang; Yongqian Shu
Journal:  Med Oncol       Date:  2015-01-29       Impact factor: 3.064

4.  Cognate CD4 T-cell licensing of dendritic cells heralds anti-cytomegalovirus CD8 T-cell immunity after human allogeneic umbilical cord blood transplantation.

Authors:  T W H Flinsenberg; L Spel; M Jansen; D Koning; C de Haar; M Plantinga; R Scholman; M M van Loenen; S Nierkens; L Boon; D van Baarle; M H M Heemskerk; J J Boelens; M Boes
Journal:  J Virol       Date:  2014-11-05       Impact factor: 5.103

Review 5.  Therapeutic vaccination with tumor cells that engage CD137.

Authors:  Karl Erik Hellstrom; Ingegerd Hellstrom
Journal:  J Mol Med (Berl)       Date:  2003-02-08       Impact factor: 4.599

6.  4-1BB functions as a survival factor in dendritic cells.

Authors:  Beom K Choi; Young H Kim; Patrick M Kwon; Sang C Lee; Sang W Kang; Moon S Kim; Myoung J Lee; Byoung S Kwon
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

7.  Helicobacter pylori induces beta3GnT5 in human gastric cell lines, modulating expression of the SabA ligand sialyl-Lewis x.

Authors:  Nuno T Marcos; Ana Magalhães; Bibiana Ferreira; Maria J Oliveira; Ana S Carvalho; Nuno Mendes; Tim Gilmartin; Steven R Head; Céu Figueiredo; Leonor David; Filipe Santos-Silva; Celso A Reis
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

8.  Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism.

Authors:  Sara Labiano; Asis Palazón; Elixabet Bolaños; Arantza Azpilikueta; Alfonso R Sánchez-Paulete; Aizea Morales-Kastresana; Jose I Quetglas; José L Perez-Gracia; Alfonso Gúrpide; Maria Rodriguez-Ruiz; M Angela Aznar; Maria Jure-Kunkel; Pedro Berraondo; Ignacio Melero
Journal:  Oncoimmunology       Date:  2015-06-24       Impact factor: 8.110

9.  Analysis of CD137 and CD137L expression in human primary tumor tissues.

Authors:  Qun Wang; Pin Zhang; Qixia Zhang; Xiaoyan Wang; Jianfeng Li; Chunhong Ma; Wensheng Sun; Lining Zhang
Journal:  Croat Med J       Date:  2008-04       Impact factor: 1.351

Review 10.  Boosting Antitumor Response by Costimulatory Strategies Driven to 4-1BB and OX40 T-cell Receptors.

Authors:  Daniele E Mascarelli; Rhubia S M Rosa; Jessica M Toscaro; Isadora F Semionatto; Luciana P Ruas; Carolinne T Fogagnolo; Gabriel C Lima; Marcio C Bajgelman
Journal:  Front Cell Dev Biol       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.